エピソード

  • Preserving Muscle Mass While Using GLP-1 Medications (Ozempic, Wegovy, Mounjaro)
    2026/04/22
    In this episode, we address the growing clinical concern of lean-mass loss associated with GLP-1 receptor agonists such as semaglutide and tirzepatide, where studies show 20 to 45 percent of weight lost can come from muscle tissue. The discussion examines the mechanisms behind this risk and presents evidence-based strategies — including higher protein intake of 1.2 to 1.6 grams per kilogram of body weight and regular resistance training — to preserve muscle while achieving the metabolic benefits of these medications. Practical guidance is provided for patients and clinicians seeking to optimize body composition outcomes during treatment.
    続きを読む 一部表示
    5 分
  • NEAT extremes- The science of spontaneous energy expenditure
    3 分
  • The 40-Gram Threshold: Timing, Tension, and Whey Efficacy
    3 分
  • Is sitting down equally harmful for everyone
    2 分
  • How can your heart rate variability predict if you’re gonna get the flu?
    3 分
  • New study shows that people over 50 who are sedentary can reverse their age by 20 years by exercising
    2 分
  • Is oat milk really that bad for you
    2 分
  • 5% of Americans are responsible for 50% of the healthcare spending
    2 分